SCHEMBL4438360

SCHEMBL4438360

COc1cc(C(C(C)=O)c2ccc(C(F)(F)F)cc2)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 1/20 0.46
TRPM8 Q7Z2W7 2/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
DYRK3 O43781 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
DYRK1A Q13627 1/20 0.38
DYRK2 Q92630 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
NR2E1 Q9Y466 1/20 0.37
CYP26A1 O43174 1/20 0.37
GRM2 Q14416 1/20 0.37
KDR P35968 1/20 0.36
PDE2A O00408 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4434628 0.79 AKR1C3 (0.51) AKR1C3AKR1C2PDE2AMAPT
SCHEMBL4433940 0.79 BCHE (0.42) AKR1C3AKR1C2KDRPDE2ABCHE
SCHEMBL4430480 0.75 AKR1C3 (0.48) AKR1C3AKR1C2MAPT
SCHEMBL4434012 0.74 TRPM8 (0.42) TRPM8PTGDR2AHR
SCHEMBL4438527 0.74 CES2 (0.50) AKR1C3AKR1C2HDAC4CES2CES1
SCHEMBL4431561 0.74 AKR1C3 (0.48) TRPM8AKR1C3AKR1C2HDAC4PDE2A
SCHEMBL4432335 0.74 CES2 (0.41) AKR1C3AKR1C2PDE2AMAPTCES2
SCHEMBL4436028 0.73 AKR1C3 (0.49) AKR1C3AKR1C2PDE2A
SCHEMBL4432351 0.73 AKR1C3 (0.49) AKR1C3AKR1C2PDE2AMAPT
SCHEMBL2304585 0.73 ACP3 (0.56) NPC1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed